Wentilactone A Reverses the NF-κB/ECM1 Signaling-Induced Cisplatin Resistance through Inhibition of IKK/IκB in Ovarian Cancer Cells
Open Access
- 14 September 2022
- Vol. 14 (18) , 3790
Abstract
Wentilactone A (WA) is a tetranorditerpenoid isolated from marine algae. We previously found that WA inhibited cancer cell proliferation with little toxicity. In this study, we show that high expression of extracellular matrix protein-1 (ECM1) promotes cancer cell cisplatin resistance, and the secreted ECM1 activates normal fibroblasts (NFs) to transform cells with characteristics of cancer-associated fibroblasts (CAFs). Transcription of the ECM1 gene is regulated largely by NF-κB through EP881C/T-EP266C binding sites. WA supresses the phosphorylation of NF-κB through inhibition of the upstream IKK/IκB phoshorylation to block the expression of ECM1, which reverses the cisplatin-induced activation of NF-κB/ECM1. On the contrary, cisplatin facilitates phosphorylation of NF-κB to enhance the expression of ECM1. These results highlight ECM1 as a potential target for treatment of cisplatin-resistant cancers associated with the ECM1 activated signaling. In addition, WA reverses cisplatin resistance by targeting both tumor cells and the tumor microenvironment through IKK/IκB/NF-κB signaling to reduce the expression of the ECM1 protein.Keywords
Funding Information
- National Natural Science Foundation of China (42076102)
- Natural Science Research Foundation of Minhang District, Shanghai (2019MHZ041)
- National Natural Science Foundation of China (82273396, 81772789, 81572553, 81372797)
This publication has 59 references indexed in Scilit:
- Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical TrialsCancer Research, 2013
- Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cellsCell Death & Disease, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerBMC Cancer, 2012
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Overexpression of ECM1 Contributes to Migration and Invasion in Cholangiocarcinoma CellNeoplasma, 2012
- The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian CancerClinical Cancer Research, 2011
- CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced AngiogenesisClinical Cancer Research, 2010
- Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2Clinical Cancer Research, 2010
- Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer ProgressionCancer Cell, 2009